These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3469285)

  • 1. [Studies on the use of CA-125 in gynecologic mass screening].
    Nakatani K; Hoshiai H; Wada Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):157-60. PubMed ID: 3469285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum CA-125 level in patients with gynecologic tumors].
    Abe Y; Ueda G; Yamasaki M; Inoue M; Hiramatsu K; Inoue Y; Saito J; Nishino T
    Rinsho Byori; 1984 Dec; 32(12):1350-4. PubMed ID: 6597876
    [No Abstract]   [Full Text] [Related]  

  • 3. [Screening for malignant gynecologic tumors].
    Ebeling K
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):715-9. PubMed ID: 8237067
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for gynecologic cancer.
    Campion MJ; Reid R
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):695-727. PubMed ID: 2092238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for gynecologic cancer].
    Yajima A; Sato S; Masuda K; Nagai H; Mori T
    Gan No Rinsho; 1990 Aug; 36(10):1128-32. PubMed ID: 2214149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer screening for women older than 40 years of age.
    Runowicz CD; Goldberg GL; Smith HO
    Obstet Gynecol Clin North Am; 1993 Jun; 20(2):391-408. PubMed ID: 8367140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organization of prophylactic gynecologic exams with mass cytological screening of women].
    Buval'tseva NA; Kvashenko BK
    Pediatr Akus Ginekol; 1978; (3):35-6. PubMed ID: 673514
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimum screening interventions for gynecologic malignancies.
    Lea JS; Miller DS
    Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA-125 and endometriosis.
    Barbieri RL
    Contrib Gynecol Obstet; 1987; 16():103-8. PubMed ID: 2446822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 72.4, SCC, 90 K].
    Garzetti GC; Di Lauro RM; Ciavattini A; Pallotta MR; Marchegiani F; Valensise H; Tranquilli AL; Arduini D; Romanini C
    Ann Ostet Ginecol Med Perinat; 1991; 112(5):320-3. PubMed ID: 1817444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
    Jacobs IJ; Oram DH; Bast RC
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of registration of gynecologic malignant neoplasms in Shizuoka Prefecture--evaluation for one and a half years].
    Hayata T; Sumimoto K; Terao T; Kawashima Y; Nagano T
    Gan No Rinsho; 1985 Feb; 31(2):179-84. PubMed ID: 3989986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening in gynecologic oncology].
    Ebeling K
    Zentralbl Gynakol; 1983; 105(19):1225-38. PubMed ID: 6316692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 15. [On a mass screening survey for gynecologic carcinomata in a rural community].
    Montanari GR; Grismondi GL; Marconato A; Gioia E; Montanari GD
    Attual Ostet Ginecol; 1968; 14(5):413-5. PubMed ID: 5737605
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of monoclonal antibody to 19-9 antigen as a potential screening technique for colorectal cancer in a high-risk population.
    Verrill H; Goldberg M; Kovac G; Atkinson B; Herlyn M
    Prog Clin Biol Res; 1984; 156():107-14. PubMed ID: 6382320
    [No Abstract]   [Full Text] [Related]  

  • 17. [The function of the mass screening center of practicing gynecologists in Bern?].
    Kaufmann P
    Gynakol Rundsch; 1977; 17(2):102-5. PubMed ID: 560331
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for gynecologic malignancies: A continuing responsibility.
    Runowicz CD; Fields AL
    Surg Oncol Clin N Am; 1999 Oct; 8(4):703-23, vii. PubMed ID: 10452936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our responsibility in the field of gynecologic cancer].
    Dolhay B; Jakubecz S; Papp Z; Herpay G; Gardó S
    Orv Hetil; 1968 Dec; 109(5):2821-5. PubMed ID: 5717809
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.